コンテンツへスキップ
Merck
  • [Role of rifaximin in correction of IBS-like symptoms in patients with inflammatory bowel disease].

[Role of rifaximin in correction of IBS-like symptoms in patients with inflammatory bowel disease].

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology (2013-12-04)
S S Belous, I L Khalif, O V Golovenko
要旨

One of the important problems in the treatment of patients with inflammatory bowel disease are the persistent complaints of pain, abdominal distention, frequent stools, excretion of mucus with faeces with the presence of endoscopic or roentgenologic remission in the damaged parts of gastrointestinal tract. In this review we describe possible causes of such complaints and some methods of their therapeutic correction.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
リファキシミン
リファキシミン, European Pharmacopoeia (EP) Reference Standard
システム適合性用リファキシミン, European Pharmacopoeia (EP) Reference Standard
Supelco
リファキシミン, VETRANAL®, analytical standard